CFB MED08 Dermatology (i)

Dermatology is the medical specialty concerned with the diagnosis and management of diseases affecting the skin, hair, nails, and mucous membranes.

Dermatology (I): Basics of Dermatology — Comprehensive Exam-Ready Notes

The Big Idea: Before you can diagnose or treat any skin disease, you must speak the language of dermatology. This lecture is the foundational toolkit — it teaches you how to describe a skin lesion precisely, how to take a dermatological history, how to examine the skin systematically, what investigations exist, and how treatments (especially topicals) work and can harm. Everything downstream — eczema, psoriasis, bullous diseases, dermatological emergencies — depends on mastering this first lecture. [1]

Learning Objectives (from the lecture): [1]

  1. How to describe a lesion
  2. How to use descriptive terms to arrive at a correct clinical diagnosis
  3. How to take a dermatological history
  4. Common investigations in dermatology
  5. Treatment in dermatological conditions

"The skin is the largest organ in the body — average weight 4 kg in an adult, surface area 1.35–2 m²." [1]

Functions of the skin:

  • Barrier/protection: physical barrier against microbes, chemicals, UV radiation
  • Temperature regulation: via vasodilation/vasoconstriction and sweating
  • Vitamin D synthesis: UVB converts 7-dehydrocholesterol in epidermis to cholecalciferol
  • Sensation: touch, pain, temperature via nerve endings
  • Immunological: Langerhans cells (dendritic cells in epidermis) serve as antigen-presenting cells

Why this matters for dermatology: When thinking about lesion types, think about the layer of skin involved — epidermis, dermis, or subcutis. The lecture explicitly links lesion morphology to skin structure. [1]

LayerKey StructuresLesion Examples
EpidermisKeratinocytes, melanocytes, stratum corneumMacules (color change only), vesicles, scaling
DermisCollagen, blood vessels, nerves, adnexaePapules, nodules, wheals, telangiectasia
SubcutisFat lobules, fibrous septaPanniculitis (erythema nodosum), deep nodules

II. Approach to Skin Disease — History & Physical Examination

A. Dermatological History

The history in dermatology is structured differently from, say, a cardiac history. The key domains, as laid out in the lecture: [1]

  • Onset: When did it first appear? Sudden vs gradual onset.
  • Time course: Acute vs chronic; intermittent vs persistent; seasonal variation (e.g., eczema worse in winter due to dry air).
  • Site: Initial site → pattern of spread → evolution (how it changes over time).
  • Aggravating factors: Scratching (Koebner phenomenon in psoriasis), cold/hot exposure, trauma, sunlight (photosensitive rashes like SLE).
  • Previous treatment and response: Critical — did topical steroids help (suggests inflammatory)? Did antifungals help (suggests tinea)? [1]

  • Skin symptoms: Itchiness (eczema, urticaria, scabies), pain (herpes zoster, cellulitis), paraesthesia/loss of sensation (leprosy, neuropathic conditions).
  • General/constitutional symptoms:
    • Acute: Fever, sweats, chills, headache, nausea/vomiting — think infection, drug reaction, or dermatological emergency.
    • Chronic: Fatigue, anorexia, weight loss, malaise — think malignancy, systemic disease with skin manifestation. [1]

Why ask about prodromal symptoms?

Prodromal symptoms help differentiate diagnoses. For example, herpes zoster typically has a prodrome of burning/tingling pain in a dermatome before vesicles appear. Drug reactions (e.g., SJS/TEN) may have a prodrome of fever and malaise before the rash develops. This sequence gives you a diagnostic timeline.

  • Drug allergy/food allergy: Essential because drug eruptions are extremely common and mimic many dermatoses.
  • Drug history/current medications: Many drugs cause skin reactions (β-blockers, antimalarials, NSAIDs, antibiotics, lithium).
  • Family/personal history: Atopy (eczema, asthma, allergic rhinitis run together), psoriasis (40% have positive family history [8]), inherited conditions (e.g., ichthyosis, epidermolysis bullosa). [1]

B. Physical Examination

"Physical examination: 4 plus cardinal features of SKIN examination: Skin + SCALP, Hair, Nail, Mucosa." [1]

This is a critical exam point — never forget to examine scalp, hair, nails, and mucosae in a dermatology station.

  • Appearance: Moon face/Cushingoid facies → suggests long-term steroid use (relevant if the skin disease itself was treated with steroids).
  • Muscle wasting/cachexia: Think underlying malignancy (paraneoplastic dermatoses).
  • Chest/abdomen: Look for surgical scars (prior operations, underlying conditions).
  • Lymph node enlargement: Could indicate lymphoma (mycosis fungoides), infection, or metastatic skin cancer.
  • Hepatosplenomegaly: Systemic diseases with skin manifestations (e.g., SLE, sarcoidosis, lymphoma).

  • Inspection: Scan head to toes systematically.
  • Palpation:

"Palpation can sometimes be more important than inspection in certain lesions (e.g., erythema nodosum — a type of panniculitis)." [1]

Why? Erythema nodosum lesions are tender, warm, subcutaneous nodules on the shins. They may look like vague areas of redness, but palpation reveals the firm, deep nodule that is pathognomonic. Similarly, morphoea (localized scleroderma) feels indurated/waxy, which you cannot appreciate by sight alone.

FeatureWhat to AssessWhy It Matters
1. Type of lesionIs it flat, raised, depressed, fluid-filled?Determines the primary morphological category → narrows DDx
2. Shape, color, borderRound, annular, linear, umbilicated; red, violaceous, brown; well-demarcated vs ill-definedWell-demarcated = psoriasis; ill-defined = eczema; violaceous = lichen planus
3. Arrangement/DistributionGrouped, scattered, dermatomal; flexural vs extensor; symmetrical vs asymmetricalDermatomal = herpes zoster; flexural = eczema; extensor = psoriasis
4. ConsistencyFirm, hard, soft, fluctuantHard = malignancy; fluctuant = abscess/cyst

III. Morphology of Skin Disease — Terminology

"Accurate/precise description of the skin lesions allows good communication and achieves the accurate diagnosis." [1]

This is the core of the lecture. You must know these terms cold for exams.

Primary Lesions — Classification by Depth/Character

TermDefinitionKey Examples
MaculeFlat, < 1 cm, color change only (not palpable)Café-au-lait spots, freckles, post-inflammatory hyperpigmentation
PatchFlat, > 1 cmVitiligo, fixed drug eruption
InfarctArea of tissue necrosis from vascular occlusionCalciphylaxis, cholesterol emboli
SclerosisHardening/thickening of skin (can appear flat but feels indurated)Morphoea, scleroderma
TelangiectasiaVisible dilated small blood vesselsRosacea, BCC, chronic sun damage, hereditary hemorrhagic telangiectasia

TermDefinitionKey Examples
PapuleRaised, solid, < 1 cmMolluscum contagiosum, lichen planus, scabies
PlaqueRaised, solid, > 1 cm, plateau-likePsoriasis, eczema, mycosis fungoides
NoduleRaised, solid, > 1 cm, round, deeperLipoma, erythema nodosum, BCC
WhealTransient, edematous, raised lesion (dermal edema)Urticaria — wheals last < 24 hours
VesicleSmall (< 1 cm) fluid-filled blister with clear fluidHerpes simplex, chickenpox, eczema herpeticum
BullaLarge (> 1 cm) fluid-filled blisterBullous pemphigoid, SJS/TEN
PustuleContains purulent materialFolliculitis (infective), pustular psoriasis (non-infective)
AbscessLarger collection of pus, deeperStaphylococcal abscess
CystEncapsulated nodule containing semisolid materialEpidermal cyst, acne cyst

Exam Trap: Not All Pustules Are Infected

A common exam pitfall: pustular psoriasis and AGEP (Acute Generalised Exanthematous Pustulosis) produce sterile pustules. The presence of pustules does NOT automatically mean bacterial infection. Always consider non-infective causes. [2]

TermDefinitionKey Examples
PetechiaeSmall (< 3 mm) non-blanching maculesThrombocytopenia, vasculitis
EcchymosisLarger (≥ 5 mm) non-blanching patchesCoagulopathy, trauma

Why non-blanching? Purpura = extravasation of RBCs into the skin. Unlike erythema (which is vasodilation and disappears when you press — blood is pushed away), extravasated blood is outside the vessel and cannot be pushed away by pressure. This is tested with diascopy (pressing a glass slide on the lesion).

TermDefinitionKey Examples
AtrophyThinning of skin (loss of epidermis ± dermis)Chronic topical steroid use
ErosionSuperficial loss of epidermis only (heals without scarring)Pemphigus vulgaris
UlcerFull-thickness loss through epidermis and into dermis (heals with scarring)Venous ulcers, arterial ulcers, pyoderma gangrenosum
SinusTract connecting a deep abscess to the skin surfacePilonidal sinus
GangreneTissue necrosisDiabetic foot, peripheral vascular disease

Erosion vs Ulcer — A Critical Distinction

  • Erosion = partial-thickness loss (epidermis only) → heals without scar
  • Ulcer = full-thickness loss (into dermis) → heals with scar
  • In pemphigus vulgaris, the split is intraepidermal (suprabasal) → flaccid blisters that rupture easily → erosions
  • In bullous pemphigoid, the split is subepidermal → tense blisters that are harder to rupture
  • This distinction directly correlates with the blister's clinical appearance and Nikolsky sign

TermDefinitionKey Examples
ScaleAccumulation of dead stratum corneumPsoriasis (silvery scale), seborrhoeic dermatitis
CrustDried serum, blood, or pus on the surfaceImpetigo (honey-colored crusts), pemphigus (crusts from erosions)
LichenificationThickening of skin with accentuated skin markings from chronic rubbingChronic atopic dermatitis
ExcoriationLinear erosion from scratchingEczema, scabies — indicates pruritus
ScarFibrous tissue replacing normal skinKeloid, hypertrophic scar
ExudateFluid (serous, purulent, or sanguineous) oozing from lesionWeeping eczema

Rule of Thumb for Scarring

"Lesions don't leave scars if the injury is above the dermis." Epidermal injury alone → no scar. Dermal injury → scar. This is why pemphigus vulgaris erosions (intraepidermal) heal with post-inflammatory hyperpigmentation but generally no true scar, unless the patient scratches deeply. [3]

ShapeDescriptionClassic Example
Round/OvalCircular or ellipticalNummular eczema
AnnularRing-shaped (active periphery, central clearing)Tinea corporis, granuloma annulare
ArciformArc-shaped (incomplete ring)Erythema marginatum
LinearIn a lineContact dermatitis (e.g., from plant), Koebner phenomenon
UmbilicatedCentral depression/dimpleMolluscum contagiosum, herpes vesicle

ArrangementDescriptionClassic Example
Isolated/ScatteredRandom distributionDrug eruption
GroupedClustered togetherHerpes simplex
HerpetiformGrouped vesicles resembling herpesDermatitis herpetiformis
ZosteriformFollowing a dermatomeHerpes zoster
AnnularRing arrangementGranuloma annulare
LinearIn a lineLichen striatus
ReticularNet-likeLivedo reticularis

Distribution encompasses: Extent, Pattern, and Characteristic location. [1]

AspectOptionsClinical Significance
ExtentGeneralized vs localizedGeneralized = systemic cause (drug reaction, viral exanthem); localized = contact dermatitis, herpes zoster
PatternSymmetrical; exposed/photosensitive areas; pressure areas; intertriginous areasSymmetrical = endogenous (eczema, psoriasis); photosensitive = SLE, drug photosensitivity; intertriginous = candida, inverse psoriasis
Characteristic locationFlexural, extensor, dermatomal, trunk, lower extremities, palms/soles, facial, genitalFlexural = eczema; extensor = psoriasis; dermatomal = zoster; palms/soles = secondary syphilis, erythema multiforme

Color:

  • Red → inflammation, infection
  • Dark red → deep inflammation
  • Violaceous (purple) → lichen planus, vasculitis, Kaposi sarcoma
  • Brown → melanin (post-inflammatory hyperpigmentation)
  • Yellow → xanthoma, jaundice
  • Dark/black → melanoma, necrosis

Special color tests:

  • Diascopy: Press glass slide on lesion → blanching (erythema from vasodilation) vs non-blanching (purpura from extravasated blood). This is a bedside test that differentiates vasculitis from simple inflammation.
  • Wood's lamp: UV light (365 nm) → certain organisms fluoresce (e.g., coral-red for erythrasma caused by Corynebacterium minutissimum; bright green for Microsporum species in tinea capitis); also enhances contrast in pigmentary disorders (vitiligo appears bright white). [1]

Border:

  • Well-demarcated: Psoriasis, tinea, fixed drug eruption
  • Ill-defined: Eczema, cellulitis

Consistency:

  • Firm → dermatofibroma
  • Hard → malignancy (BCC, SCC)
  • Soft/fluctuant → lipoma, cyst

IV. Investigations in Dermatology

"Ix: usually limited and not routine → clinical data of paramount importance." [7]

Most dermatological diagnoses are clinical. Investigations serve to confirm the diagnosis, identify the causative organism, or assess systemic involvement.

  • CBC: Eosinophilia (drug reaction, atopic dermatitis, parasites); leukocytosis (infection); thrombocytopenia (purpura)
  • LRFT (Liver and Renal Function Tests): Baseline before starting systemic therapy (methotrexate → hepatotoxic; cyclosporine → nephrotoxic)
  • Serology: Autoantibodies (ANA for SLE, anti-skin antibodies for pemphigus/pemphigoid); syphilis serology; HIV
  • Urinalysis, stool: Systemic involvement assessment

InvestigationWhat It DetectsClinical Use
Skin biopsyHistopathology — the gold standard for many dermatosesDifferentiates psoriasis from eczema; diagnoses bullous diseases, vasculitis, malignancy
Gram stain of crustBacterial morphologyImpetigo, infected wounds
KOH preparationFungal hyphae/yeast formsTinea (dermatophyte infection), candidiasis
Tzanck smearMultinucleated giant cellsHSV, VZV (but cannot distinguish between them — PCR is more specific)
Culture (wound swab/tissue)Bacterial, mycobacterial, fungal organismsIdentifies specific pathogen and antibiotic sensitivities
Wood's lampFluorescence patternErythrasma (coral-red), tinea capitis (Microsporum = green), vitiligo (enhanced depigmentation)
Scraping for scabies/mitesIdentifies Sarcoptes scabiei mite, eggs, or fecal pelletsScabies diagnosis
Patch testIdentifies Type IV (delayed) hypersensitivity allergensAllergic contact dermatitis — applied for 48 hours, read at 48 and 96 hours
Acetone whiteningTest for nickel sensitivityDimethylglyoxime test — rub acetone-moistened swab on metal object

High Yield: Patch Test vs Prick Test vs RAST

  • Patch test = Type IV delayed hypersensitivity (allergic contact dermatitis) — allergen applied to skin for 48h [1]
  • Skin prick test = Type I immediate hypersensitivity (IgE-mediated, e.g., food allergy, drug allergy) — read at 15-20 min
  • RAST (Radioallergosorbent test) = measures serum-specific IgE — unreliable as noted by senior notes [7]
  • The key differentiator tested in exams: timing — Type I occurs within minutes to 1 hour; Type IV occurs after 48-72 hours [9]

ConditionHistopathological Finding
Bullous pemphigoidIgG deposition along basement membrane zone; subepidermal blister with eosinophils
Pemphigus vulgarisIgG deposition at intercellular layer of epidermis; suprabasal acantholysis
Atopic dermatitis (eczema)Spongiosis within the epidermis
PsoriasisPsoriasiform hyperplasia with absent granular layer
Erythema nodosumSeptal panniculitis without vasculitis
Erythema induratumLobular panniculitis with vasculitis
Lupus panniculitisLobular panniculitis without vasculitis

V. Treatment in Dermatology

CategoryOptions
No treatmentObservation (some benign lesions, e.g., seborrhoeic keratosis)
Topical medicationEmollients, steroids, antifungals, antibiotics, retinoids, calcineurin inhibitors
Systemic medicationOral steroids, immunosuppressants (methotrexate, cyclosporine, azathioprine), biologics
SurgicalExcision, incision & drainage, curettage, electrocauterization, cryotherapy
PhototherapyUVB, PUVA, Re-PUVA, methotrexate-phototherapy
Laser therapyPigment laser, vascular laser, fractional ablative laser
OtherChemical peeling, liposuction, autologous hair transplant, epidermal graft (vitiligo), iontophoresis, vaccines, Botox, fillers

"Rule of thumb: wet lesions (e.g., weeping/burn) — use high-water content applications; dry lesions — use ointment base." [1]

Oil content spectrum (decreasing oil, increasing water): Oil > Ointment > Paste > Cream > Lotion > Collodion > Gel

BaseWater ContentOil ContentBest For
OintmentLowHighDry, chronic, lichenified skin (e.g., chronic eczema); provides occlusion → enhances drug absorption
CreamModerateModerateGeneral use; most cosmetically acceptable
Lotion/GelHighLowWet/weeping lesions, hairy areas, burns

Why does this matter? Occluding a wet/weeping lesion with ointment traps moisture → maceration → worsens infection. Conversely, applying lotion to dry, cracked skin provides insufficient moisturization.

Components of topical preparations: [1]

  • Active ingredients: Corticosteroid, dithranol/tar, antiseptics, antibiotics, antifungals, antivirals, retinoid acid, benzoyl peroxide
  • Other components: Preservatives (can cause allergic contact dermatitis), vehicles, fragrances (another common allergen)

This is extremely high yield for exams. The HK steroid ladder is commonly tested.

ClassPotencySteroid ExampleTrade Name
Class IVMild (mildest)1% hydrocortisone acetate—
Class IIIModerate0.05% clobetasone butyrateEumovate
Class IIPotent0.25% fluocinolone acetonideSynalar
Class IVery potent0.05% clobetasol propionateDermovate

High Yield: Steroid Potency Selection Principles

  • Face, genitalia, flexures: Use mild (Class IV: hydrocortisone) — thin skin absorbs more → higher risk of atrophy and striae
  • Body/trunk: Use moderate (Class III: Eumovate)
  • Palms, soles (thick skin): May need potent (Class II) or very potent (Class I) because thick stratum corneum limits absorption
  • Absorption by body site (from Ryan Ho): sole of foot 0.14%, palm 0.83%, forearm 1%, scalp 3.5%, forehead 6%, mandible 13%, genitalia 42% [7]
  • Duration: Intermittent with tapering — avoid continuous use (→ tolerance + rebound)

Adverse Effects of Topical Steroids [1]

"LOCAL: Aggravation of infection (cellulitis, impetiginised eczema, eczema herpeticum), skin atrophy, striae, telangiectasia, tachyphylaxis, rebound phenomenon on withdrawal." [1]

Local EffectMechanism
Infection aggravationSteroids suppress local immune response → allows bacteria (impetiginised eczema), viruses (eczema herpeticum), fungi (tinea incognito) to flourish
Skin atrophySteroids inhibit collagen synthesis by fibroblasts → thinning of dermis
StriaeDermal collagen breakdown → permanent stretch marks (irreversible!)
TelangiectasiaLoss of dermal support → superficial vessels become visible
TachyphylaxisReduced response with chronic continuous use → need to take "steroid holidays"
Rebound phenomenonSudden withdrawal → flare of disease worse than original (especially dangerous in psoriasis → can trigger erythroderma or pustular psoriasis)

Tinea Incognito

Applying topical steroids to a fungal infection (misdiagnosed as eczema) partially suppresses inflammation → the rash looks atypical and is harder to diagnose → this is called "tinea incognito." Always do KOH preparation before starting steroids on an annular, well-demarcated, scaly lesion to exclude tinea. [1]

These apply to both oral/systemic AND excessive topical steroid use (especially potent steroids over large areas, under occlusion, or on thin skin).

Systemic adverse effects include: Adrenal suppression, Cushing's syndrome, growth retardation, hypertension, DM/glucose intolerance, acneiform eruption, hirsutism, skin atrophy, striae, muscle wasting, scalp hair loss/thinning, poor wound healing, osteoporosis, AVN of hip, infection, GI complications (gastritis, GI bleeding), cataracts, glaucoma, CNS effects (agitation, insomnia). [1]

"Esterified steroids (new formula): quickly metabolized by skin cells, thus not systemically absorbed/distributed." [1]

This is an important concept — newer esterified steroids (e.g., methylprednisolone aceponate) are designed to be potent locally but are rapidly deactivated when they enter the bloodstream, reducing systemic side effects. This is particularly useful for children and for sensitive areas.

AgentUseNotes
Tar, salicylic acidPsoriasis (keratolytic)Salicylic acid dissolves keratin → removes scale
CalcipotriolPsoriasis (vitamin D analogue)Reduces keratinocyte proliferation
Benzyl benzoateScabies treatmentApplied whole body below neck
AntisepticsIruxol, silver nitrateWound care
AntifungalsImidazoles (clotrimazole), miconazoleTinea, candida
AntibioticsNeomycin, gentamicin, fusidic acid (Fucidin), mupirocin (Bactroban)Impetigo, infected eczema
AntiviralAcyclovir creamHSV — limited efficacy topically; systemic acyclovir is preferred for significant infections
Retinoid derivativeAdapalene (Differin)Acne — avoid pregnancy, advise contraception, potential teratogenicity
Benzoyl peroxideAcneBactericidal against P. acnes; can bleach clothing
SulphurVarious (scabies, acne)Traditional agent

Retinoid Teratogenicity

All retinoids (topical or systemic) are teratogenic. Women of childbearing age must use reliable contraception. Isotretinoin (systemic) requires a pregnancy test before starting, monthly during treatment, and contraception for 1 month after stopping. Acitretin (used in psoriasis) requires contraception for 3 years after stopping because it is stored in fat. [1]

TypeMechanismIndications
Narrowband UVB (NB-UVB)UV light induces immunosuppression in the skin; inhibits T cell proliferationPsoriasis, eczema, vitiligo, cutaneous T-cell lymphoma
PUVAPsoralen (photosensitizer) + UVA → cross-links DNA in proliferating cellsPsoriasis, vitiligo, mycosis fungoides
Re-PUVARetinoid + PUVA → combination allows lower UV dosesSevere psoriasis
MTX + phototherapyMethotrexate + phototherapyRecalcitrant psoriasis

Risks of phototherapy: Skin aging, increased skin cancer risk with cumulative doses (especially PUVA), phototoxic burns.

"Laser therapy depends on the chromophore: melanin, hemoglobin, water." [1]

Laser TypeTarget ChromophoreWavelengthIndications
Pigment laserMelanin1064 nm, 755 nmFreckles, lentigines, solar lentigo
Vascular laser (PDL)Hemoglobin595 nmPort-wine stain, hemangioma, keloid scar, rosacea
Fractional ablative laserWaterCO₂ or ErbiumAcne scars, skin resurfacing — minimizes downtime

TreatmentIndication
IontophoresisHyperhidrosis (excess sweating of palms/soles) — uses electrical current to deliver ions through skin
VaccinesVZV (chickenpox prevention, shingles prevention); melanoma vaccine (immunotherapy)
Botox injectionHyperhidrosis (blocks acetylcholine release at neuromuscular junction of eccrine sweat glands); cosmetic wrinkle reduction
FillersCosmetic volume restoration
Chemical peelingSkin rejuvenation
Epidermal graftVitiligo (transplant melanocytes from normal skin to depigmented areas)

Anti-pruritic effect — important in eczema, urticaria, drug eruptions.

GenerationSedationExamplesKey Points
1st generationSedatingChlorpheniramine (Piriton), polaramine, hydroxyzine (Atarax), promethazine (Phenergan), doxepin (anxiolytic effect)Must warn patient not to drive if taking sedating antihistamines [1]
2nd generationLow-sedating/non-sedatingCetirizine (Zyrtec), loratadine (Clarityne), fexofenadine (Telfast)For patients who need to be alert, drive, or operate machinery [1]

Antihistamine in Eczema

In atopic dermatitis, the itch is mainly mediated by cytokines (IL-31, TSLP) rather than histamine. Antihistamines in eczema work primarily through their sedative effect (1st gen), helping patients sleep rather than directly blocking the itch pathway. This is why senior dermatologists say antihistamines for eczema are "mainly as sedative." [2]

For chronic urticaria: 2nd generation antihistamines are first-line, can be uptitrated to up to 4 times the standard dose before adding other agents. [10]



The GC lecture on skin rash covers:

  • Skin basics (overlaps with this lecture)
  • Cutaneous manifestation of systemic disease
  • Life-threatening dermatoses (blistering diseases, erythroderma)
  • Common dermatoses
  • Treatment in dermatology

This Derm I lecture provides the foundational vocabulary needed for GC 085 and GC 065 (itchy rash).

Derm II focuses on dermatological emergencies — SJS/TEN, erythroderma, pemphigus/pemphigoid, eczema herpeticum. Understanding the basics from Derm I is prerequisite.

Expands on management of eczema, psoriasis, and urticaria. Key addition: biologics (dupilumab for eczema, anti-IL-17/23 for psoriasis, omalizumab for chronic urticaria).

EMQ themes commonly tested:

  • Match description → diagnosis (2019 MCQ Q1-2: neurofibromatosis, spider naevi) [4]
  • Match histopathology → diagnosis (2021 MCQ: bullous pemphigoid, erythema nodosum, psoriasis) [5]
  • Identify skin lesion type from clinical photo or description
  • Topical steroid potency and adverse effects
  • Drug allergy workup (2025 MCQ Q82: LTT for delayed drug hypersensitivity) [14]
  • Skin cancer identification (2023 Q61: BCC vs SCC vs melanoma) [6]

TrapCorrect Understanding
Confusing macule and patchMacule < 1 cm; Patch > 1 cm — same thing, just size difference
Confusing vesicle and bullaVesicle < 1 cm; Bulla > 1 cm — both contain clear fluid
All pustules = infectionNO — pustular psoriasis and AGEP have sterile pustules
Blanching vs non-blanchingErythema = blanching (vasodilation); Purpura = non-blanching (extravasated blood)
Erosion vs ulcerErosion = epidermis only → no scar; Ulcer = into dermis → scars
Well-demarcated vs ill-definedWell-demarcated = psoriasis, tinea; Ill-defined = eczema
Flexural vs extensorFlexural = eczema; Extensor = psoriasis
Dermovate is "mild"NO — Dermovate (clobetasol propionate) is the MOST potent (Class I)
Hydrocortisone is "potent"NO — 1% hydrocortisone is the MILDEST (Class IV)
Antihistamines "treat" eczema itchThey mainly provide sedation; eczema itch is cytokine-mediated, not purely histamine-mediated

High Yield Summary

  1. Key takeaways from Dermatology I

  2. Summary

      1. History: Onset, time course, site, spread, aggravating factors, prior treatment, drug/allergy/family history, symptoms (itch, pain, constitutional).
  3. Summary

    • 2. Examination: Always check Skin + Scalp + Hair + Nails + Mucosa. Use inspection AND palpation.
  4. Summary

    • 3. 4 Cardinal Features: Type of lesion, Shape/Color/Border, Arrangement/Distribution, Consistency.
  5. Summary

    • 4. Lesion terminology: Know flat (macule/patch), raised (papule/plaque/nodule/wheal/vesicle/bulla/pustule/cyst), depressed (erosion/ulcer/atrophy), secondary (scale/crust/lichenification/excoriation).
  6. Summary

    • 5. Distribution clues: Flexural = eczema; Extensor = psoriasis; Dermatomal = zoster; Photosensitive = SLE; Symmetrical = endogenous.
  7. Summary

    • 6. Investigations: Clinical diagnosis is paramount. Biopsy, KOH, Tzanck smear, Wood's lamp, patch test for specific indications.
  8. Summary

    • 7.
    • Topical treatment: Match base to lesion (wet → wet, dry → ointment).
    • Know steroid potency ladder (Class IV = mildest hydrocortisone → Class I = most potent Dermovate).
    • Know local and systemic side effects of steroids.
  9. Summary

    • 8. Antihistamines: 1st gen = sedating (warn about driving); 2nd gen = non-sedating (safe for daytime use).
  10. Summary

    1. Phototherapy: UVB, PUVA, Re-PUVA for psoriasis, eczema, vitiligo.
  1. Summary
    1. Retinoids are teratogenic — contraception mandatory.

Active Recall - Dermatology I: Basics of Dermatology

[1] Lecture slides: CFB (MED08) Dermatology (I).pdf (all pages) [2] Senior notes: Maksim Medicine Notes.pdf (Dermatology section, pp. 66-68) [3] Senior notes: Block A - Dermatology PBL 2.pdf (p. 1, erosion/crust/scarring discussion) [4] Past papers: 2019 Fourth Summative MCQ.pdf (Section B, Q1-2) [5] Past papers: 2021 Fourth Summative Assessment MCQ.pdf (Section B, Q1-5) [6] Past papers: 2023 Fourth Summative MCQ.pdf (Q61) [7] Senior notes: Ryan Ho Fundamentals.pdf (pp. 412, 419) [8] Senior notes: Ryan Ho Rheumatology.pdf (p. 120, psoriasis genetics) [9] Senior notes: Block A - Fundamentals of Allergology.pdf (p. 3, Type I vs Type IV timing) [10] Senior notes: Block A - Treatments for skin diseases (eczema, psoriasis and urticaria).pdf (p. 46) [11] Lecture slides: GC 085. Skin rash_Doctor I have a rash.pdf (p. 5) [12] Lecture slides: CFB (MED09) Dermatology (II).pdf (p. 2) [13] Past papers: 2025 Fourth Summative MCQ.pdf (Q82, Q21-25) [14] Past papers: 2025 Fourth Summative MCQ.pdf (Q82)

On this page

No Headings